NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,878,000 | -26.5% | 27,200 | -3.2% | 0.18% | -65.8% |
| Q3 2017 | $2,554,000 | +7.2% | 28,100 | -12.2% | 0.54% | -8.5% |
| Q2 2017 | $2,382,000 | -31.3% | 32,000 | -13.5% | 0.59% | -43.2% |
| Q1 2017 | $3,467,000 | -4.6% | 37,000 | -26.0% | 1.04% | -64.2% |
| Q4 2016 | $3,633,000 | -27.2% | 50,000 | +4.6% | 2.90% | +48.6% |
| Q3 2016 | $4,990,000 | -7.9% | 47,800 | -34.9% | 1.95% | -16.2% |
| Q2 2016 | $5,420,000 | -35.8% | 73,475 | -41.2% | 2.33% | +84.2% |
| Q4 2015 | $8,439,000 | +56.9% | 125,000 | +7.8% | 1.26% | -65.7% |
| Q3 2015 | $5,378,000 | -39.9% | 115,927 | -30.4% | 3.68% | +41.6% |
| Q2 2015 | $8,947,000 | +231.0% | 166,450 | +195.1% | 2.60% | +162.9% |
| Q1 2015 | $2,703,000 | – | 56,400 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |